Emergent BioSolutions Stock Income Statements

Emergent BioSolutions Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Operating Profit

Net Income

Emergent BioSolutions Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2017-12-31	2017-03-31	2016-12-31	2016-03-31	2015-12-31	2015-03-31	2013-12-31	2013-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31

revenues:
product sales	173,850,000	249,800,000	302,200,000	143,400,000	305,700,000	186,200,000	237,200,000	237,100,000	434,300,000	270,500,000	181,200,000	137,900,000	340,900,000	202,200,000	298,500,000	148,200,000	310,800,000	256,200,000	183,500,000	153,000,000	339,547,000	81,969,000	224,572,000	71,706,000	338,625,000	18,291,000	185,520,000	30,359,000	81,670,000	43,663,000	71,479,000	5,597,000	89,390,000	67,266,000	55,872,000	38,853,000	47,160,000	39,004,000	69,330,000	61,678,000	29,816,000	55,478,000	42,326,000	41,504,000	80,049,000	41,786,000	22,518,000	25,446,000
contract development and manufacturing
services	20,600,000	13,200,000	26,400,000	13,400,000	17,700,000	36,200,000	2,700,000	51,800,000	51,200,000	112,600,000
leases	200,000	1,000,000	2,700,000	1,800,000	200,000	200,000	-4,500,000	9,000,000	167,100,000	-71,000,000
total cdmo revenues	14,425,000	14,200,000	29,100,000	15,200,000
contracts and grants	6,700,000	6,500,000	6,600,000	6,500,000	7,100,000	17,400,000	7,300,000	9,600,000	70,600,000	16,900,000	25,400,000	21,300,000	43,000,000	25,900,000	23,600,000	22,600,000	24,100,000	35,600,000	41,000,000	21,700,000	53,161,000	17,261,000					53,268,000	12,741,000	26,278,000	15,099,000	16,662,000	12,936,000	13,857,000	6,720,000	6,266,000	7,947,000	6,644,000	4,268,000	3,861,000	2,841,000	5,934,000	1,121,000	1,159,000	1,216,000	9,588,000	1,858,000	668,000	1,002,000
total revenues	276,600,000	270,500,000	337,900,000	165,100,000	330,700,000	240,000,000	242,700,000	307,500,000	723,200,000	329,000,000	397,500,000	343,000,000	583,000,000	385,200,000	394,700,000	192,500,000	360,300,000	311,800,000	243,200,000	190,600,000	444,015,000	116,858,000	377,780,000	111,002,000	459,156,000	63,633,000	238,788,000	43,100,000	107,948,000	58,762,000	88,141,000	18,533,000	103,247,000	73,986,000	62,138,000	46,800,000	53,804,000	43,272,000	73,191,000	64,519,000	35,750,000	56,599,000	43,485,000	42,720,000	89,637,000	43,644,000	23,186,000	26,448,000
yoy	-16.36%	12.71%	39.23%	-46.31%	-54.27%	-27.05%	-38.94%	-10.35%	24.05%	-14.59%	0.71%	78.18%	61.81%	23.54%	62.29%	1.00%	-18.85%	166.82%	-35.62%	71.71%	-3.30%	83.64%	58.21%	157.55%	325.35%	8.29%	170.92%	132.56%	4.55%	-20.58%	41.85%	-60.40%	91.89%	70.98%	-15.10%	-27.46%	50.50%	-23.55%	68.31%	51.03%	-60.12%	29.68%	87.55%	61.52%
qoq	2.26%	-19.95%	104.66%	-50.08%	37.79%	-1.11%	-21.07%	-57.48%	119.82%	-17.23%	15.89%	-41.17%	51.35%	-2.41%	105.04%	-46.57%	15.55%	28.21%	27.60%	-57.07%	279.96%	-69.07%	240.34%	-75.82%	621.57%	-73.35%	454.03%	-60.07%	83.70%	-33.33%	375.59%	-82.05%	39.55%	19.07%	32.77%	-13.02%	24.34%	-40.88%	13.44%	80.47%	-36.84%	30.16%	1.79%	-52.34%	105.38%	88.23%	-12.33%
operating expenses:
cost of product sales	92,150,000	132,500,000	134,900,000	102,900,000	167,300,000	85,500,000	91,000,000	80,300,000	145,000,000	103,200,000																	40,379,000	5,698,000	14,328,000	10,706,000	16,069,000	1,068,000	16,998,000	11,532,000	11,076,000	7,508,000	11,782,000	8,684,000	10,428,000	15,368,000	6,870,000	10,519,000	8,682,000	8,010,000	17,544,000	11,407,000	5,842,000	5,516,000
cost of cdmo	37,925,000	44,300,000	55,700,000	52,200,000	52,100,000	63,100,000
goodwill impairment		218,200,000
impairment of long-lived assets			306,700,000
research and development	29,400,000	15,300,000	26,000,000	40,600,000	57,600,000	39,200,000	49,800,000	46,400,000	83,000,000	49,600,000	48,900,000	52,500,000	59,500,000	84,400,000	47,900,000	42,700,000	62,800,000	53,400,000	63,900,000	46,100,000	76,908,000	20,476,000	74,136,000	34,154,000	115,295,000	38,702,000	89,502,000	30,724,000	29,376,000	29,216,000	31,481,000	34,759,000	29,615,000	21,156,000	18,602,000	19,922,000	19,226,000	18,772,000	20,680,000	15,910,000	14,162,000	16,627,000	17,206,000	11,475,000	12,269,000	12,777,000	13,342,000	15,570,000
selling, general and administrative	89,700,000	86,000,000	91,400,000	100,500,000	94,200,000	80,200,000	81,100,000	84,800,000	94,200,000	82,100,000	91,200,000	80,900,000	82,100,000	75,500,000	76,000,000	69,700,000	72,200,000	65,000,000	70,800,000	65,400,000	108,347,000	35,150,000	103,902,000	39,784,000	113,965,000	34,493,000	55,990,000	20,028,000	18,254,000	17,432,000	20,384,000	18,212,000	21,671,000	20,693,000	17,649,000	16,192,000	18,671,000	19,767,000	19,373,000	15,975,000	13,864,000	14,115,000	15,039,000	12,060,000	16,666,000	15,038,000	12,659,000	11,193,000
amortization of intangible assets	16,200,000	16,300,000	16,100,000	17,000,000	17,900,000	14,000,000	14,000,000	14,000,000	14,000,000	14,500,000	15,100,000	14,900,000	15,000,000	15,000,000	15,000,000	14,800,000	14,800,000	14,700,000		14,500,000
total operating expenses	320,400,000	512,600,000	630,800,000	313,200,000	395,800,000	282,000,000	314,700,000	301,100,000	445,800,000	363,700,000	383,000,000	247,600,000	324,900,000	323,900,000	268,700,000	204,100,000	282,600,000	241,100,000	250,200,000	217,800,000
income from operations	-43,800,000	-242,100,000	-292,900,000	-148,100,000	-65,100,000	-42,000,000	-72,000,000	6,400,000	277,400,000	-34,700,000	14,500,000	95,400,000	258,100,000	61,300,000	126,000,000	-11,600,000	77,700,000	70,700,000	-7,000,000	-27,200,000	109,375,000	14,910,000	96,961,000	8,561,000	124,349,000	-28,310,000	43,317,000	-13,350,000	45,990,000	1,408,000	20,207,000	-35,506,000	34,963,000	20,605,000	14,811,000	3,178,000	4,125,000	-3,951,000	22,710,000	17,266,000	854,000	15,338,000	2,558,000	11,175,000	43,158,000	4,422,000	-8,657,000	-5,831,000
yoy	-32.72%	476.43%	306.81%	-2414.06%	-123.47%	21.04%	-596.55%	-93.29%	7.48%	-156.61%	-88.49%	-922.41%	232.18%	-13.30%	-1900.00%	-57.35%	-28.96%	374.18%	-107.22%	-417.72%	-12.04%	-152.67%	123.84%	-164.13%	170.38%	-2110.65%	114.37%	-62.40%	31.54%	-93.17%	36.43%	-1217.24%	747.59%	-621.51%	-34.78%	-81.59%	383.02%	-125.76%	787.80%	54.51%	-98.02%	246.86%	-129.55%	-291.65%
qoq	-81.91%	-17.34%	97.77%	127.50%	55.00%	-41.67%	-1225.00%	-97.69%	-899.42%	-339.31%	-84.80%	-63.04%	321.04%	-51.35%	-1186.21%	-114.93%	9.90%	-1110.00%	-74.26%	-124.87%	633.57%	-84.62%	1032.59%	-93.12%	-539.24%	-165.36%	-424.47%	-129.03%	3166.34%	-93.03%	-156.91%	-201.55%	69.68%	39.12%	366.05%	-22.96%	-204.40%	-117.40%	31.53%	1921.78%	-94.43%	499.61%	-77.11%	-74.11%	875.98%	-151.08%	48.47%
operating margin %	-15.84%	-89.50%	-86.68%	-89.70%	-19.69%	-17.50%	-29.67%	2.08%	38.36%	-10.55%	3.65%	27.81%	44.27%	15.91%	31.92%	-6.03%	21.57%	22.67%	-2.88%	-14.27%	24.63%	12.76%	25.67%	7.71%	27.08%	-44.49%	18.14%	-30.97%	42.60%	2.40%	22.93%	-191.58%	33.86%	27.85%	23.84%	6.79%	7.67%	-9.13%	31.03%	26.76%	2.39%	27.10%	5.88%	26.16%	48.15%	10.13%	-37.34%	-22.05%
other income:
interest expense	-21,700,000	-19,700,000	-28,600,000	-17,900,000	-12,800,000	-8,500,000	-7,800,000	-8,200,000	-9,000,000	-8,400,000	-8,600,000	-8,500,000	-8,700,000	-7,600,000	-6,400,000	-8,600,000	-9,100,000	-10,300,000	-9,500,000	-9,600,000	-4,652,000	-1,938,000	-6,093,000	-1,524,000	-4,862,000	-1,661,000	5,000	-11,000			-6,000				-2,000	-5,000	7,000	-4,000				2,000			-17,000		-21,000	-26,000
gain on sale of business		-700,000	74,900,000
other	11,000,000	-3,400,000	-3,600,000	4,900,000	6,700,000	-13,400,000	-3,000,000	-2,000,000	-900,000	-2,400,000	1,300,000	-1,700,000	3,400,000	1,300,000	1,100,000
total other income	-10,700,000	-23,800,000	42,700,000	-13,000,000	-6,100,000	-21,900,000	-10,800,000	-10,200,000	-9,900,000	-10,800,000	-7,300,000	-10,200,000	-5,300,000	-6,300,000	-5,300,000	-9,700,000	-6,200,000	-11,800,000	-8,100,000	-10,600,000	-4,387,000	-1,265,000	-5,079,000	-1,222,000	-4,791,000	-1,479,000	2,069,000	29,000	-228,000	59,000	-21,000	34,000	19,000	-965,000	380,000	375,000	372,000	428,000	289,000	272,000	309,000	477,000	650,000	650,000	839,000	451,000	579,000	1,025,000
income before income taxes	-54,500,000	-265,900,000	-250,200,000	-161,100,000	-71,200,000	-63,900,000	-82,800,000	-3,800,000	267,500,000	-45,500,000	7,200,000	85,200,000					1,475,000	58,900,000	-15,100,000
income tax benefit	-5,000,000	-2,500,000	11,100,000	21,900,000	3,675,000	-11,800,000							8,675,000	15,500,000	28,000,000	8,800,000	-425,000	15,700,000		-11,800,000
net income	-49,500,000	-263,400,000	-261,300,000	-183,000,000	-88,000,000	-75,700,000	-56,400,000	-3,700,000	189,300,000	-32,700,000	4,600,000	69,700,000	185,400,000	39,500,000	92,700,000	-12,500,000	46,900,000	43,200,000	-9,500,000	-26,000,000	72,109,000	10,485,000	47,785,000	3,991,000	84,390,000	-21,520,000	26,948,000	-8,805,000	26,900,000	-137,000	12,523,000	-23,173,000	23,888,000	11,944,000	9,434,000	1,918,000	3,661,000	-539,000	13,251,000	10,172,000	1,455,000	10,386,000	1,815,000	7,024,000	27,741,000	2,845,000	-4,961,000	-2,690,000
yoy	-43.75%	247.95%	363.30%	4845.95%	-146.49%	131.50%	-1326.09%	-105.31%	2.10%	-182.78%	-95.04%	-657.60%	295.31%	-8.56%	-1075.79%	-51.92%	-34.96%	312.02%	-119.88%	-751.47%	-14.55%	-148.72%	77.32%	-145.33%	213.72%	15608.03%	115.19%	-62.00%	12.61%	-101.15%	32.74%	-1308.19%	552.50%	-2315.96%	-28.81%	-81.14%	151.62%	-105.19%	630.08%	44.82%	-94.76%	265.06%	-136.59%	-361.12%
qoq	-81.21%	0.80%	42.79%	107.95%	16.25%	34.22%	1424.32%	-101.95%	-678.90%	-810.87%	-93.40%	-62.41%	369.37%	-57.39%	-841.60%	-126.65%	8.56%	-554.74%	-63.46%	-136.06%	587.73%	-78.06%	1097.32%	-95.27%	-492.15%	-179.86%	-406.05%	-132.73%	-19735.04%	-101.09%	-154.04%	-197.01%	100.00%	26.61%	391.87%	-47.61%	-779.22%	-104.07%	30.27%	599.11%	-85.99%	472.23%	-74.16%	-74.68%	875.08%	-157.35%	84.42%
net income margin %	-17.90%	-97.38%	-77.33%	-110.84%	-26.61%	-31.54%	-23.24%	-1.20%	26.18%	-9.94%	1.16%	20.32%	31.80%	10.25%	23.49%	-6.49%	13.02%	13.86%	-3.91%	-13.64%	16.24%	8.97%	12.65%	3.60%	18.38%	-33.82%	11.29%	-20.43%	24.92%	-0.23%	14.21%	-125.04%	23.14%	16.14%	15.18%	4.10%	6.80%	-1.25%	18.10%	15.77%	4.07%	18.35%	4.17%	16.44%	30.95%	6.52%	-21.40%	-10.17%
net income per common share
basic	-880,000	-5,080,000	-5,150,000		-1,760,000	-1,520,000	-1,130,000	-70,000	3,540,000	-610,000	90,000	1,310,000	570,000	750,000	1,760,000	-240,000	37,500	840,000	-180,000	-510,000
diluted	-880,000	-5,080,000	-5,150,000		-1,760,000	-1,520,000	-1,130,000	-70,000	3,500,000	-610,000	90,000	1,280,000	557,500	730,000	1,730,000	-240,000	37,500	830,000	-180,000	-510,000
weighted-average shares outstanding
basic	51,200,000	51,800,000	50,700,000	50,200,000
diluted	51,200,000	51,800,000	50,700,000	50,200,000
cdmo:
loss per common share
basic				-3,650,000
diluted				-3,650,000
total cdmo					17,900,000	36,400,000
shares used in computing net income per common share
basic					-100,000	49,900,000	50,000,000	50,700,000	-0.1	53.7	53.6	53.3	13.125	53	52.6	52	12.85	51.6	51.5	51.2
diluted					-100,000	49,900,000	50,000,000	50,700,000	-0.2	53.7	54	54.5	13.4	54.3	53.5	52	13.075	52.3	51.5	51.2
contract development and manufacturing:
total contract development and manufacturing							-1,800,000	60,800,000	104,075,000	41,600,000
cost of contract development and manufacturing							78,800,000	75,600,000	76,900,000	114,300,000
income taxes							26,400,000	100,000	88,800,000	12,800,000	-2,600,000	-15,500,000
shares used in computing income per share
basic					-100,000	49,900,000	50,000,000	50,700,000	-0.1	53.7	53.6	53.3	13.125	53	52.6	52	12.85	51.6	51.5	51.2
diluted					-100,000	49,900,000	50,000,000	50,700,000	-0.2	53.7	54	54.5	13.4	54.3	53.5	52	13.075	52.3	51.5	51.2
contract development and manufacturing services											190,900,000	183,800,000	199,100,000	157,100,000	72,600,000	21,700,000
cost of product sales and contract development and manufacturing services											227,800,000	99,300,000	168,300,000	149,000,000	129,800,000	76,900,000
income before benefit for income taxes													38,600,000	55,000,000
income before benefit from income taxes															120,700,000	-21,300,000				-37,800,000			1,834,750	7,339,000	119,558,000	-29,789,000	45,386,000	-13,321,000	45,762,000	1,467,000	20,186,000	-35,472,000	34,982,000	19,640,000	15,191,000	3,553,000	4,497,000	-3,523,000	22,999,000	17,538,000			3,208,000	11,825,000	43,997,000	4,873,000	-8,078,000	-4,806,000
other income																-1,100,000	2,900,000	-1,500,000	1,400,000	-1,000,000	-1,115,000	300,000	147,000	116,000	-419,000	100,000	1,953,000	17,000	-252,000	37,000	-39,000	-1,000	-11,000	-1,003,000	6,000	-8,000	-22,000	6,000	-10,000	-24,000	-49,000		198,000	-14,000	-8,000	-14,000	1,000	177,000
shares used in computing loss per share
basic					-100,000	49,900,000	50,000,000	50,700,000	-0.1	53.7	53.6	53.3	13.125	53	52.6	52	12.85	51.6	51.5	51.2
diluted					-100,000	49,900,000	50,000,000	50,700,000	-0.2	53.7	54	54.5	13.4	54.3	53.5	52	13.075	52.3	51.5	51.2
contract manufacturing																	13,650,000	20,000,000	18,700,000	15,900,000	51,307,000	17,628,000	41,551,000	7,587,000	30,725,000	12,243,000
cost of product sales and contract manufacturing																	75,175,000	108,000,000	100,800,000	91,800,000	149,385,000	46,322,000	102,781,000	28,503,000	105,547,000	18,748,000
amortization of acquisition-related intangible assets																			14,700,000
income tax (benefit) expense																			-5,600,000
interest income																					1,380,000	373,000	867,000	186,000	490,000	82,000	111,000	23,000	24,000	22,000	24,000	35,000	30,000	38,000	376,000	388,000	387,000	426,000	305,000	300,000	401,000	476,000	457,000	665,000	864,000	472,000	599,000	874,000
income from continuing operations before benefit from income taxes																					104,988,000	13,645,000
benefit from income taxes																					32,879,000	3,160,000	33,349,000	3,348,000	35,168,000	-8,269,000	18,438,000	-4,516,000	18,862,000	1,604,000	7,663,000	-12,299,000	11,094,000	7,696,000	5,757,000	1,635,000	836,000	-2,984,000	9,748,000	7,366,000	4,000	5,857,000	1,393,000	4,801,000	16,256,000	2,028,000	-3,117,000	-2,116,000
net income from continuing operations																					72,109,000	10,485,000
net income from discontinued operations
net income from continuing operations - basic																					65	260
net income from discontinued operations - basic
net income per share																					1.72	0.26	1.46	0.1
net income from continuing operations - diluted																					0.058	0.23
net income from discontinued operations - diluted
weighted-average number of shares - basic													52.7				51.5				41,816,431	40,727,755	40,184,159	39,542,656	38,595,435	37,949,358	36,080,495	35,968,064	35,658,907	35,855,217	35,619,514	35,179,317	31,782,286	31,301,796	31,097,445	30,879,970	30,444,485		30,271,317	30,184,098	29,835,134	29,818,994	29,763,872	29,750,237	28,995,667	29,739,797	28,599,405	27,864,328
weighted-average number of shares - diluted													53.8				52.4				50,327,937	49,718,426	49,335,112	48,359,892	47,255,842	37,949,358	36,420,662	35,968,064	36,206,052	36,447,933	36,667,452	35,179,317	32,539,500	32,113,313	31,900,000	31,432,751	31,375,305		30,949,612	31,454,456	30,458,098	30,590,950	30,044,691	29,819,727	29,663,127	29,900,571	28,599,405	27,864,328
contracts, grants and collaborations																							7,927,250	31,709,000	89,806,000	33,099,000
operating expense:
loss per share - basic																											-0.055	-0.22
loss per share - diluted																									-0.143	-0.57	-0.055	-0.22
impairment of in-process research and development
net income attributable to noncontrolling interest																											4,638,000	743,000					2,359,000	1,176,000	374,000	605,000	573,000	1,488,000	1,591,000	947,000
net income attributable to emergent biosolutions inc.																											31,586,000	-8,062,000	28,657,000	1,549,000	14,210,000	-21,397,000	26,247,000	13,120,000	9,808,000	2,523,000	4,234,000	949,000	14,842,000	11,119,000
net income attributable to noncontrolling interests																													1,287,250	1,686,000	1,687,000	1,776,000
earnings per share - basic																													0.81	0.04	0.4	-0.61	0.81	0.42	0.32	0.08			0.49	0.37	0.04	0.35	0.06	0.24	0.96	0.1	-0.17	-0.1
earnings per share - diluted																													0.8	0.04	0.39	-0.61	0.79	0.41	0.31	0.08			0.48	0.35	0.04	0.34	0.06	0.24	0.94	0.1	-0.17	-0.1
earnings per share — basic																																					0.223	0.03
earnings per share — diluted																																					0.215	0.03
weighted-average number of shares — basic																																						30,506,661
weighted-average number of shares — diluted																																						31,534,831
minority interest in subsidiary																																									296,000	428,000
income before benefit from
(benefit from) income taxes																																									7,819,500	16,243,000
purchased in-process research and development

We provide you with 20 years income statements for Emergent BioSolutions stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Emergent BioSolutions stock. Explore the full financial landscape of Emergent BioSolutions stock with our expertly curated income statements.

The information provided in this report about Emergent BioSolutions stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.